Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Low- and High-Tech Assessments

Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Low- and High-Tech Assessments

Abstract Introduction An innovative eye drops formulation containing 0.2% hyaluronic acid and a low concentration of hydrocortisone (0.001%; hereafter HALH) has been recently placed on the market (Idroflog®, Alfa Intes, Italy) to manage the dysregulated parainflammation in patients with dry eye dise...

Full description

Bibliographic Details
Main Authors: Paolo Fogagnolo, Giuseppe Giannaccare, Rita Mencucci, Edoardo Villani, Vincenzo Orfeo, Pasquale Aragona, Italian Dry Eye Study Group
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-11-01
Series:Ophthalmology and Therapy
Subjects:
Dry eye disease
DED
Hydrocortisone
Inflammation
Tear film
Lubricating eye drops
Online Access:https://doi.org/10.1007/s40123-023-00833-7

Internet

https://doi.org/10.1007/s40123-023-00833-7

Similar Items